SNCA and Parkinson disease: As amyloid β plaques and tau neurofibrillary tangles are also observed post-mortem in patients with advanced PD [34], future longitudinal follow-up studies concomitantly incorporating assessments of different post-translationally modified forms of α-synuclein, amyloid β protein, and total and phospho-tau in plasma may be needed to better predict PD progression.